The introduction of esketamine nasal spray represents a significant shift in the treatment of treatment-resistant depression across Europe . While traditionally requiring hospital-based administration, https://spravato-online-vendor-i406793.blogproducer.com/49950021/copyright-a-promising-treatment-a-new-hope-for-depression-in-european-countries